Compare Heron Therapeutics Inc (HRTX) vs Prudential Financial Inc (PRU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Heron Therapeutics Inc vs Prudential Financial Inc — how do they compare? Heron Therapeutics Inc trades at $0.37 (market cap $74.04M), while Prudential Financial Inc trades at $112.85 (market cap $39.17B). The key difference: Prudential Financial Inc is far larger — about 529× Heron Therapeutics Inc's market cap, and Prudential Financial Inc pays a 4.93% dividend while Heron Therapeutics Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Heron Therapeutics Inc for 35 Days and Prudential Financial Inc for 145 Days on average.
| HRTX | PRU | |
|---|---|---|
Market Cap | $74.04M | $39.17B |
Volume | 3,668,095 | 1,436,917 |
Sector | Health | Financials |
52-Week High | $1.49 | $125.13 |
52-Week Low | $0.27 | $92.00 |
Typical Hold Time | 35 Days | 145 Days |
Enterprise Value | $180.78M | $67.95B |
Dividend Yield | — | 4.93% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HRTX trades at $0.39, up 17.58% today, with a bullish technical signal from moving averages. The company reported Q2 2026 revenue of $37.7 million but missed EPS estimates with a $0.03 loss. Despite negative profitability metrics, analyst consensus remains strongly positive with 89% buy ratings. Recent news highlights ongoing comparisons with peers and earnings performance discussions.
The outlook is mixed: strong analyst support and technical momentum suggest potential upside, but persistent losses and high valuation ratios pose significant risks. Investment opportunity hinges on revenue growth translating to profitability, while key risks include execution challenges and competitive pressures in the biotechnology sector.
Prudential Financial (PRU) trades at $112.36, down 1.04% with a bearish technical outlook. The stock shows attractive valuation metrics including a P/E of 10.19 and P/S of 0.61, while recent earnings beat expectations in two of the last three quarters. The company is executing a strategic overhaul including a $3 billion capital rotation plan and emerging market exits, while benefiting from higher interest rates that boost investment income.
PRU presents a value opportunity with strong fundamentals but faces near-term technical pressure. The 67.57% analyst hold rating reflects cautious optimism, with the current price above the $105.67 consensus target. Key risks include execution of strategic initiatives and annuity market competition, while higher rates provide tailwinds for insurance operations.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Heron Therapeutics Inc
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →About Prudential Financial Inc
Prudential Financial is a large, diversified insurance company offering annuities, life insurance, retirement plan services, and asset management products. While it operates in a number of countries, the vast majority of revenue is generated in the United States and Japan. The company's investment management business, PGIM, contributes approximately 15% of its earnings and has over $1.5 trillion in assets under management. The U.S. businesses are responsible for about 45% of earnings and can be classified into Institutional Retirement Strategies, Individual Retirement Strategies, Group Insurance, Individual Life Insurance, and Assurance IQ. Finally, the international business segment of the company contributes approximately 40% of earnings with a strong market position in Japan.
Read more on PRU →
